Merit Medical Pays Endogastric Solutions $105M for Acid Reflux Treatment

Merit Medical Systems has acquired an acid reflux treatment from Endogastric Solutions for $105M. Endogastric Solutions’ minimally invasive device, Esophyx Z+, is designed to treat gastroesophageal reflux disease (GERD) by restoring the barrier that stops acid from the stomach entering the esophagus.  

GERD affects around 20% of people in the U.S., making it one of the most commonly diagnosed digestive disorders in the country. Patients develop symptoms such as heartburn because the failure of a barrier in the gastrointestinal tract exposes the esophagus to stomach acids. Lifestyle changes and medicines are first-line treatments, but surgery is considered when those interventions fail to improve outcomes. 

The post Merit Medical Pays Endogastric Solutions $105M for Acid Reflux Treatment appeared first on Life Science Washington.

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks